 - Patients must demonstrate evidence of progressive disease based on 1 of the following criteria: 1 Progressive measurable disease, or 2 Progressive rise in prostate-specific antigen PSA level 2 consecutive rises from a prior reference level, or 3 Development of new lesions on bone scan. 